Tmunity Therapeutics, with ties to Penn Medicine, once raised $231 million from investors. Now workers and its Center City office are gone.

Cell and gene therapy leaders say the agency’s decision to remove the Risk Evaluation and Mitigation Strategies that had been ...

Market Growth Driven by Increasing Drug Approvals, Advanced Technologies, Rising Chronic Disease Incidence, and Expanding Therapeutic Applica ...

Crypto infrastructure provider Banxa Holdings (TSXV: BNXA) is set to be acquired by the Hong Kong-listed OSL Group. The transaction will see Banxa acquired for all cash as OSL works to grow its ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases.

Proposed reverse merger with OrthoCellix, a wholly-owned subsidiary of Ocugen, to create Nasdaq-listed, late clinical-stage regenerative cell therapy company with a first-in-class technology ...